Clinical Trial Update: A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing standard therapy for limited-stage Hodgkin lymphoma to a regimen incorporating Brentuximab Vedotin and Nivolumab; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 | Phase 3 | Status: RECRUITING